MannKind | MNKD - Market Capitalization


MannKind reported $1.5B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 3.49B 853M Sep/2025
BioCryst Pharmaceuticals USD 1.23B 115M Dec/2023
Eli Lilly USD 1.01T 3.37B Feb/2026
Halozyme Therapeutics USD 10.23B 2.31B Feb/2026
Insmed USD 23.91B 13.21B Feb/2026
MacroGenics USD 114M 8M Feb/2026
MannKind USD 1.65B 511M Sep/2025
Merck USD 300.37B 39.11B Feb/2026
Minerva Neurosciences USD 43M 5M Dec/2023
Novavax USD 684M 43M Sep/2023
Novo Nordisk DKK 246.32B 60.06B Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
Sanofi EUR 100.88B 4.46B Dec/2025
Xencor USD 837M 278M Sep/2025